Intervacc is a startup based in Sweden. Brouky records 1 investor associated with the company.
Intervacc is a Swedish biotechnology company that develops recombinant protein-based vaccines and pharmaceuticals for animal health, focusing on improving animal welfare and protecting against bacterial infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.